Clinical Trials on Gram-negative Bacteraemia in China

Total 595 results

Fujian Cancer Hospital

Enrolling by invitation

Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLC

EGFR/ ALK-negative Advanced NSCLC

China
G1 Therapeutics, Inc.

Active, not recruiting

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) (PRESERVE 2)

Breast Cancer | TNBC - Triple-Negative Breast Cancer

United States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
Baodong Qin

Unknown

Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC

NSCLC Stage IV | Anlotinib | EGFR T790M-negative | JS001

China
Hoffmann-La Roche

Completed

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) (IMpassion131)

Triple-Negative Breast Cancer

France, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Pneumoniae Epidemiology Study in China

Pneumococcal Disease

China
Haihe Biopharma Co., Ltd.

Unknown

Glumetinib Combined With Osimertinib in the Treatment of Relapsed and Metastatic Non-small Cell Lung Cancer Patients Who Failed to Receive EGFR Inhibitors

Negative T790M Mutation and Met Amplification

China
Shanghai Jiatan Pharmatech Co., Ltd

Completed

Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081 (WX-081)

Pulmonary Tuberculosis

China
Huashan Hospital

Recruiting

TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts (TB-YOUTH)

Latent Tuberculosis | Tuberculosis

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

The Study of Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic Monitoring

Untreated Advanced NSCLC Patients | FISH Identified ALK Fusion Positive or Negative

China
Peking University Third Hospital

Completed

Vancomycin Dosage Strategy Based on a Trough Concentration Model

Pneumonia, Staphylococcal

China
Huashan Hospital
Red Cross Hospital, Hangzhou, China; Wenzhou Central Hospital

Unknown

Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects

Tuberculosis, Pulmonary

China
Beijing Chest Hospital

Unknown

Study on the Management Model of "Home Treatment" for Tuberculosis Patients

Tuberculosis, Pulmonary

China
Fudan University
Huazhong University of Science and Technology; LinkDoc Technology (Beijing)...

Recruiting

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Triple-negative Breast Cancer | Carcinoma Breast | Invasive Ductal Carcinoma, Breast

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer

HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer

China
Zhinan Yin, Ph.D.
Shenzhen Third People's Hospital

Unknown

Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells (MDR-TB)

Multi-drug Resistant Tuberculosis

China
Novartis Vaccines

Completed

Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children

Haemophilus Influenzae Type b (Hib) Infection

China
GlaxoSmithKline

Completed

Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.

Tetanus | Diphtheria | Acellular Pertussis

China
Jinling Hospital, China

Unknown

Biotherapy for MRSA Enterocolitis

Methicillin-Resistant Staphylococcus Aureus

China
AstraZeneca
Daiichi Sankyo

Active, not recruiting

A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)

Carcinoma, Non-Small-Cell Lung | Triple Negative Breast Cancer

China
Gilead Sciences

Recruiting

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-03)

Triple Negative Breast Cancer | PD-L1 Negative

United States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
Shanghai Public Health Clinical Center
Zhejiang University; Yunnan Provincial Infectious Disease Hospital; Shenzhen... and other collaborators

Unknown

Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis (RRHT)

Tuberculosis, Pulmonary | AIDS

China
Chengdu CoenBiotech Co., Ltd
Jiangsu Province Centers for Disease Control and Prevention; Changde First... and other collaborators

Recruiting

Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.

Tuberculosis

China
Huashan Hospital
The Second Hospital of Hebei Medical University; Tongji Hospital; The Affiliated... and other collaborators

Recruiting

The Prevalence and Reproductive Outcome of Infertile Women With Genital Tuberculosis (TB-PRIME)

Infertility, Female | Genital Tuberculoses, Female

China
Chengdu CoenBiotech Co., Ltd
Beijing Friendship Hospital; Beijing Chest Hospital, Capital Medical University

Completed

Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis

Tuberculosis

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

NTM-LD Treatment Based on GenSeizer Characteristic Gene Capture Strategy

Non - Tuberculosis Mycobacteria Lung Disease

China
GlaxoSmithKline

Completed

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

Tetanus | Diphtheria | Acellular Pertussis

China
Beijing Friendship Hospital

Recruiting

Comparison of Three Different Puncture Techniques in EBUS-TBNA

Lung Cancer | Tuberculosis | Sarcoidosis

China
Sanofi

Terminated

Efficacy and Safety of Teicoplanin in CDAD

Clostridium Difficile Infection-associated Diarrhea and Colitis

China
Fifth Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB

Pulmonary Tuberculosis

China
CanSino Biologics Inc.

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Tetanus

China
Second Affiliated Hospital, School of Medicine,...

Unknown

Identifcation of Biomarkers for Active Pulmonary Tuberculosis

Tuberculosis | Diagnosis

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Completed

Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

Pneumonia, Pneumococcal

China
Chinese University of Hong Kong
Guangzhou Institute of Respiratory Disease

Completed

Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou

Pulmonary Tuberculosis

China
The Second Hospital of Nanjing Medical University
Wuhan University; The First Affiliated Hospital of Zhengzhou University; First... and other collaborators

Recruiting

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

Antibiotic-associated Diarrhea | Intestinal Infection | Clostridioides Difficile Infection

China
The University of Hong Kong
The University of Hong Kong-Shenzhen Hospital

Completed

MRI Differentiating Gut TB and Crohn's

Crohn Disease | Intestinal Tuberculosis

China
Huashan Hospital

Recruiting

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) (INSPIRE-TB)

Multidrug Resistant Tuberculosis

China
Beijing Chest Hospital
The First Affiliated Hospital with Nanjing Medical University; Anhui Chest... and other collaborators

Recruiting

Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis

Tuberculosis | Treatment | Adjuvant

China
CanSino Biologics Inc.

Recruiting

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Tetanus

China
Fujian Provincial Hospital

Completed

Multicenter Study of Tetanus Patients in Fujian Province of China

Tetanus

China
GlaxoSmithKline

Completed

Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

Tetanus | Diphtheria | Acellular Pertussis

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Recruiting

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

Healthy Volunteers

China
CanSino Biologics Inc.

Recruiting

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Pertussis | Tetanus | Diphtheria

China
Jiangsu HengRui Medicine Co., Ltd.

Enrolling by invitation

Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative

Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast Cancer

China
Sinovac Life Sciences Co., Ltd.

Recruiting

Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population

Tetanus

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
National Institutes for Food and Drug Control, China; Simoon Record Pharma... and other collaborators

Unknown

Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months

Pneumonia, Pneumococcal

China
Chinese PLA General Hospital

Unknown

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Pancreatic Cancer | Malignant Mesothelioma | Triple Negative Breast Cancer | Endometrial Cancer | Ovarian Tumor | Other Mesothelin Positive Tumors

China
Peking University First Hospital

Unknown

Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China

Staphylococcal Infections | Acute Kidney Injury | Adverse Effect | Cross-sectional Study | Vancomycin

China
Peking University Cancer Hospital & Institute

Unknown

Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors

Pancreatic Cancer | Gastric Adenocarcinoma | Cholangiocarcinoma | HER2-negative Breast Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China
Centers for Disease Control and Prevention; Zhejiang University; Jiangsu Province... and other collaborators

Unknown

Research on New Regimens for Retreatment Pulmonary Tuberculosis

Reinfection Pulmonary Tuberculosis

China
National Center for AIDS/STD Control and Prevention...
Sichuan Center for Disease Control and Prevention; Guizhou Center for Disease... and other collaborators

Unknown

Injecting Drug Use Community Intervention Trial

HIV Infections | Hepatitis C | HIV | HSV-2 | Syphilis

China

Clinical Trials on Gram-negative Bacteraemia in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations